Combined detection of circulating tumor cells, α-fetoprotein heterogene-3 and α-fetoprotein in the early diagnosis of HCC for the prediction of efficacy, prognosis, recurrence after microwave ablation

Combined detection of circulating tumor cells, α-fetoprotein heterogene-3 and α-fetoprotein in the early diagnosis of HCC for the prediction of efficacy, prognosis, recurrence after microwave ablation

Abstract Background Early diagnosis can significantly improve treatment outcomes for hepatocellular carcinoma (HCC) patients. Currently, the dosage of serum alpha fetoprotein (AFP) is widely used in the diagnosis of HCC, but this biomarker has low specificity and may cause false positive or false ne...

Full description

Bibliographic Details
Main Authors: Jian Zhou, Yue Zhu, Yi Li, Kun Liu, Fei He, Sihuan Xu, Xin Li, Li Li, Junfang Hu, Yan Liu
Format: Article
Language:English
Published: BMC 2021-05-01
Series:Infectious Agents and Cancer
Subjects:
Circulating tumor cells
α-fetoprotein alloplasm 3
α-fetoprotein
Hepatocellular carcinoma
Microwave ablation
Online Access:https://doi.org/10.1186/s13027-021-00367-2

Internet

https://doi.org/10.1186/s13027-021-00367-2

Similar Items